[Hepatitis D screening is important in the Czech Republic as well].

Q3 Medicine
Petr Husa, Svatava Snopková, Petr Husa
{"title":"[Hepatitis D screening is important in the Czech Republic as well].","authors":"Petr Husa,&nbsp;Svatava Snopková,&nbsp;Petr Husa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Only patients infected with hepatitis B virus (HBV) can contract hepatitis D virus (HDV) infection, either simultaneously (co-infection) or as a superinfection in those already infected with HBV. The routes of HDV transmission are contaminated needles or transfusion; sexual and vertical transmissions are relatively rare. Chronic hepatitis D is the most serious form of chronic viral hepatitis due to more rapid progression to decompensated cirrhosis and hepatocellular carcinoma (HCC). Liver cirrhosis may develop within five years and HCC within 10 years of dual infection. In the vast majority of cases, HDV replication suppresses HBV replication. Therefore, most patients are positive for HDV RNA in plasma while showing no or low levels of HBV DNA. At present, there is no routine screening for HDV in persons with chronic HBV infection in the Czech Republic. One of the reasons the absence of approved treatment op-tions, with the only possibility being administration of pegylated interferon alpha for 48 weeks or even longer. This approach does not provide long-term efficacy in most cases. Therapy with bulevirtide seems to be promising according to available data.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"27 3","pages":"98-103"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka mikrobiologie a infekcni lekarstvi","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Only patients infected with hepatitis B virus (HBV) can contract hepatitis D virus (HDV) infection, either simultaneously (co-infection) or as a superinfection in those already infected with HBV. The routes of HDV transmission are contaminated needles or transfusion; sexual and vertical transmissions are relatively rare. Chronic hepatitis D is the most serious form of chronic viral hepatitis due to more rapid progression to decompensated cirrhosis and hepatocellular carcinoma (HCC). Liver cirrhosis may develop within five years and HCC within 10 years of dual infection. In the vast majority of cases, HDV replication suppresses HBV replication. Therefore, most patients are positive for HDV RNA in plasma while showing no or low levels of HBV DNA. At present, there is no routine screening for HDV in persons with chronic HBV infection in the Czech Republic. One of the reasons the absence of approved treatment op-tions, with the only possibility being administration of pegylated interferon alpha for 48 weeks or even longer. This approach does not provide long-term efficacy in most cases. Therapy with bulevirtide seems to be promising according to available data.

[D型肝炎筛查在捷克共和国也很重要]。
只有感染乙型肝炎病毒(HBV)的患者才能同时感染丁型肝炎病毒(HDV),要么同时感染(合并感染),要么在已经感染乙型肝炎病毒的患者中发生重复感染。艾滋病毒的传播途径是受污染的针头或输血;性传播和垂直传播相对罕见。慢性丁型肝炎是最严重的一种慢性病毒性肝炎,由于其发展为失代偿性肝硬化和肝细胞癌(HCC)的速度更快。双重感染可在5年内发生肝硬化,10年内发生HCC。在绝大多数情况下,HDV复制抑制HBV复制。因此,大多数患者血浆中HDV RNA呈阳性,而HBV DNA水平不高或较低。目前,捷克共和国没有对慢性乙型肝炎病毒感染者进行常规筛查。其中一个原因是缺乏批准的治疗方案,唯一的可能性是给药聚乙二醇干扰素α 48周甚至更长时间。这种方法在大多数情况下不能提供长期疗效。根据现有资料,用布利韦肽治疗似乎是有希望的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Klinicka mikrobiologie a infekcni lekarstvi
Klinicka mikrobiologie a infekcni lekarstvi Medicine-Infectious Diseases
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信